CD9 and neoplasm: Notably, the significant increase in prevalence of CD147+ EVs was detected substantially earlier than for CD9+ EVs, that is at day 28 for CD147+ EVs when mean tumour size is 176 mm3 (Figure 6c) versus day 42 for CD9+ EVs when mean tumour size is 691 mm3 (Figure 6b).